Brief: Synact Pharma Management, Chairman Have Acquired Shares
Dec 22 (Reuters) - SynAct Pharma AB SYNACT.ST: SYNACT PHARMA MANAGEMENT AND CHAIRMAN OF THE BOARD HAVE ACQUIRED SHARES SYNTACT EXECUTIVES AND CHAIRMAN BUY SHARES CHAIRMAN OF BOARD, ANDERS KRONBORG HAS ACQUIRED 3,470 SHARES CEO JEPPE ØVLESEN, CSO THOMAS JONASSEN, AND CBO MADS BJERREGAARD, HAVE ACQUIRED 8,558 SHARES Source text: ID:nMFN65sxYB Further company coverage: SYNACT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))
Recent news on SynAct Pharma AB
See all newsSweden's SynAct Pharma Q3 net loss narrows as expenses fall
Brief: SynAct Pharma Q3 Net Income SEK -32.177 Million
Brief: SynAct Pharma Signs First Commercial Partnership For Resomelagon
Brief: WHO Names Resomelagon Among Key Dengue Drug Candidates
Brief: SynAct Pharma Says Advance Analysis Supports Phase 3 Development